Surgical management of early stage melanoma | 31 min 1
In this presentation, Surgical Oncologist Prof Andrew Spillane discusses:PRESENTER
• management of the primary tumour
• the role of sentinel lymph node biopsy and its importance in adjuvant therapy and clinical trials
• multidisciplinary management of high-risk melanoma
• management of macroscopic nodal disease, including adjuvant and neoadjuvant therapy.
This presentation is suitable for Oncologists, Skin Cancer GPs, General GPs, Nurses and other healthcare professionals.
This presentation was recorded at the 2022 Tasmanian Clinical Education Evening, organised by Skin Cancer Tasmania part of Melanoma Institute Australia.
Prof Andrew Spillane
Surgical Oncologist, Melanoma Institute Australia | Professor of Surgical Oncology, The University of Sydney
Declaration of Interest
[miniorange_social_login shape="longbuttonwithtext" theme="default" space="4" width="240" height="40"]
Login with your site account
Register a new accountMelanoma Institute Australia uses website cookies to improve your browsing experience when using our website. ACCEPTREJECT